ArticleHeliyon2025
Prophylactic antibiotics in laparoscopic cholecystectomy: Reducing postoperative infection risk-A meta-analysis and trial sequential analysis.
Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation of Risk Factors for Postoperative Infection in 176 Patients Undergoing Laparoscopic Cholecystectomy at a Single Center.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
- Perioperative Antimicrobial Prophylaxis in Elective and High-Risk Laparoscopic Cholecystectomy: A Narrative Review.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of prophylactic antibiotics on postoperative infection following laparoscopic cholecystectomy remains controversial. This meta-analysis and trial sequential analysis aims to assess the efficacy of prophylactic antibiotics in reducing the risk of postoperative infection following laparoscopic cholecystectomy. Methods: Multiple databases including PubMed, Cochrane Library, EMBASE, and Web of Science were systematically searched to identify relevant randomized controlled trials (RCTs) published from inception to January 23, 2024. This study analyzed endpoints such as infection complications (IC) and surgical site infections (SSI). RCTs comparing prophylactic antibiotics versus placebo or no treatment in patients undergoing laparoscopic cholecystectomy were included. Data extraction and meta-analysis were performed. Additionally, trial sequential analysis was conducted to assess the robustness of evidence in meta-analysis. Results: Thirty-six RCTs with 9386 patients were included. The IC and SSI in prophylactic antibiotics group were significantly lower [pooled log risk-ratio (log RR): 0.37, 95 % confidence interval (CI):(-0.60, -0.14), p = 0.0017; pooled log RR: 0.30, 95 % CI (-0.51, -0.09), p = 0.01]. Trial sequential analysis revealed relative risk reductions of 33.09 % for IC and 27.96 % for SSI. Trial sequential analysis suggesting that the current evidence is robust. Studies involving low-risk patients and those with acute cholecystitis inclusion did not demonstrate a clear advantage in SSI reduction with prophylactic antibiotics. Conclusion: Prophylactic antibiotics significantly reduces the risk of postoperative infection in patients undergoing laparoscopic cholecystectomy. Moreover, the lack of research on the impact of prophylactic antibiotics on postoperative infections in patients with acute cholecystitis undergoing laparoscopic cholecystectomy underscores the importance of further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.